Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: Preliminary in-vitro findings

Marilena Crescente; Chiara Cerletti; Giovanni de Gaetano

doi:10.1160/TH07-01-0056

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 97(06): 1054-1056
DOI: 10.1160/TH07-01-0056

Letters to the Editor

Schattauer GmbH

Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: Preliminary in-vitro findings

Authors

Marilena Crescente

¹Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Chiara Cerletti

¹Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
Giovanni de Gaetano

¹Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy

Abstract

Full Text

References

References
1 Ohno Y, Fukuda K, Takemura G. et al Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999; 10: 845-851.
2 Appeldoorn CC, Bonnefoy A, Lutters BC. et al Gallic acid antagonizes P-selectin-mediated plateletleukocyte interactions: implications for the French paradox. Circulation 2005; 111: 106-112.
3 de Gaetano G, Cerletti C, Dejana E. et al Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185-1193.
4 Livio M, Del Maschio A, Cerletti C. et al Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 1982; 23: 787-796.
5 MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003; 361: 573-574.
6 Shahrzad S, Aoyagi K, Winter A. et al Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 2001; 131: 1207-1210.
7 Kuriyama S, Shimazu T, Ohmori K. et al Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. J Am Med Assoc 2006; 296: 1255-1265.
8 Trichopoulou A, Costacou T, Bamia C. et al Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-2608.
9 Konishi Y, Hitomi Y, Yoshioka E. Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. J Agric Food Chem 2004; 52: 2527-2532.
10 de Gaetano G, Cerletti C. Aspirin resistance: a revival of platelet aggregation tests?. J Thromb Haemost 2003; 1: 2048-2061.
11 Maree AO, Fitzgerald DJ. Aspirin and coronary artery disease. Thromb Haemost 2004; 92: 1175-1181.
12 Szczeklik A, Musial J, Undas A. et al Aspirin resistance. J Thromb Haemost 2005; 3: 1655-1662.
13 Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.